9 results  1 of 1 

1 Malignant Mixed Mullerian tumors of the ovary: The result of Platinum-based combination chemotherapy following the cytoreductive surgery
Jin Young Ma, Yong Man Kim, Min Hyung Jung, Sang Min Park, Dae Yeon Kim, Jong Hyeok Kim, Young Tak Kim, Joo Hyun Nam, Jung Eun Mok
Korean J Gynecol Oncol.2005;16(1):46-52.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgo.2005.16.1.46
      
2 The Ability of Preoperative Serum CA-125 level to Predict the Outcome of Primary Cytoreductive Surgery of Epithelial Ovarian Carcinoma
Han Moie Park, Yoon Soo Kim, Eun Kyoung Shin, Mi Kyoung Kim, Kyung Ah Jung, Mi Hye Park, Sun Hee Chun, Jung Ja Ahn, Chong Il Kim, Seung Cheol Kim
Korean J Gynecol Oncol Colposc.2003;14(2):158-166.   Published online 2019 March 12     DOI: http://dx.doi.org/10.3802/kjgoc.2003.14.2.158
      
3 Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Treatment Options for Peritoneal Metastasis of Advanced Gastric Cancer
Dong-Wook Kim, Dong-Guk Park, Sanghyun Song, Ye Seob Jee
J Gastric Cancer.2018;18(3):296-304.   Published online 2018 September 27     DOI: http://dx.doi.org/10.5230/jgc.2018.18.e32
      
4 Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer
Giorgio Bogani, Diego Rossetti, Antonino Ditto, Fabio Martinelli, Valentina Chiappa, Lavinia Mosca, Umberto Leone Roberti Maggiore, Stefano Ferla, Domenica Lorusso, Francesco Raspagliesi
J Gynecol Oncol.2018;29(5):e66.  Published online 2018 April 23     DOI: http://dx.doi.org/10.3802/jgo.2018.29.e66
      
5 Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer: 2-year follow-up results at a single institution in Korea
Min Hyeong Jo, Jung Wook Suh, Jeong Seok Yun, Hwan Namgung, Dong-Guk Park
Ann Surg Treat Res.2016;91(4):157-164.   Published online 2016 September 30     DOI: http://dx.doi.org/10.4174/astr.2016.91.4.157
      
6 Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer
Libing Xiang, Yunxia Tu, Tiancong He, Xuxia Shen, Ziting Li, Xiaohua Wu, Huijuan Yang
J Gynecol Oncol.2016;27(6):e62.  Published online 2016 August 2     DOI: http://dx.doi.org/10.3802/jgo.2016.27.e62
      
7 Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer
Jaeman Bae, Myong Cheol Lim, Jae-Ho Choi, Yong-Joong Song, Kyoung-Soo Lee, Sokbom Kang, Sang-Soo Seo, Sang-Yoon Park
J Gynecol Oncol.2009;20(2):101-106.   Published online 2009 June 29     DOI: http://dx.doi.org/10.3802/jgo.2009.20.2.101
      
8 Long-Surviving Patients with Recurrent GIST after Receiving Cytoreductive Surgery with Imatinib Therapy
Won Hyuk Choi, Sungsoo Kim, Woo Jin Hyung, Jeong Sik Yu, Chan Il Park, Seung Ho Choi, Sung Hoon Noh
Yonsei Med J.2009;50(3):437-440.   Published online 2009 June 23     DOI: http://dx.doi.org/10.3349/ymj.2009.50.3.437
      
9 Clinical analysis for the prognostic factors in patients with recurrent epithelial ovarian cancer who underwent secondary cytoreductive surgery
Hee Seung Kim, Tae Hun Kim, Hyun Hoon Chung, Jae Weon Kim, Noh-Hyun Park, Yong-Sang Song, Soon-Beom Kang
Korean J Gynecol Oncol.2008;19(1):75-80.   Published online 2008 March 20     DOI: http://dx.doi.org/10.3802/kjgo.2008.19.1.75
      

 1 of 1